3-193637313-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_130837.3(OPA1):​c.1035+32T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 1,412,594 control chromosomes in the GnomAD database, including 131,541 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14101 hom., cov: 30)
Exomes 𝑓: 0.43 ( 117440 hom. )

Consequence

OPA1
NM_130837.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0240

Publications

32 publications found
Variant links:
Genes affected
OPA1 (HGNC:8140): (OPA1 mitochondrial dynamin like GTPase) The protein encoded by this gene is a nuclear-encoded mitochondrial protein with similarity to dynamin-related GTPases. The encoded protein localizes to the inner mitochondrial membrane and helps regulate mitochondrial stability and energy output. This protein also sequesters cytochrome c. Mutations in this gene have been associated with optic atrophy type 1, which is a dominantly inherited optic neuropathy resulting in progressive loss of visual acuity, leading in many cases to legal blindness. [provided by RefSeq, Aug 2017]
OPA1 Gene-Disease associations (from GenCC):
  • autosomal dominant optic atrophy, classic form
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • optic atrophy
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • OPA1-related optic atrophy with or without extraocular features
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • Behr syndrome
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant optic atrophy plus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 3-193637313-T-C is Benign according to our data. Variant chr3-193637313-T-C is described in ClinVar as Benign. ClinVar VariationId is 95730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPA1NM_130837.3 linkc.1035+32T>C intron_variant Intron 10 of 30 ENST00000361510.8 NP_570850.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPA1ENST00000361510.8 linkc.1035+32T>C intron_variant Intron 10 of 30 5 NM_130837.3 ENSP00000355324.2

Frequencies

GnomAD3 genomes
AF:
0.428
AC:
64673
AN:
151178
Hom.:
14087
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.412
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.411
Gnomad ASJ
AF:
0.419
Gnomad EAS
AF:
0.332
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.541
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.435
Gnomad OTH
AF:
0.413
GnomAD2 exomes
AF:
0.424
AC:
105597
AN:
249148
AF XY:
0.420
show subpopulations
Gnomad AFR exome
AF:
0.416
Gnomad AMR exome
AF:
0.399
Gnomad ASJ exome
AF:
0.422
Gnomad EAS exome
AF:
0.332
Gnomad FIN exome
AF:
0.546
Gnomad NFE exome
AF:
0.437
Gnomad OTH exome
AF:
0.424
GnomAD4 exome
AF:
0.428
AC:
539842
AN:
1261294
Hom.:
117440
Cov.:
17
AF XY:
0.426
AC XY:
271417
AN XY:
637656
show subpopulations
African (AFR)
AF:
0.417
AC:
12253
AN:
29360
American (AMR)
AF:
0.400
AC:
17652
AN:
44132
Ashkenazi Jewish (ASJ)
AF:
0.427
AC:
10561
AN:
24730
East Asian (EAS)
AF:
0.285
AC:
10953
AN:
38416
South Asian (SAS)
AF:
0.377
AC:
30598
AN:
81164
European-Finnish (FIN)
AF:
0.544
AC:
28788
AN:
52924
Middle Eastern (MID)
AF:
0.370
AC:
1988
AN:
5366
European-Non Finnish (NFE)
AF:
0.434
AC:
404460
AN:
931602
Other (OTH)
AF:
0.421
AC:
22589
AN:
53600
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
14192
28384
42575
56767
70959
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11440
22880
34320
45760
57200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.428
AC:
64731
AN:
151300
Hom.:
14101
Cov.:
30
AF XY:
0.430
AC XY:
31745
AN XY:
73878
show subpopulations
African (AFR)
AF:
0.412
AC:
16981
AN:
41224
American (AMR)
AF:
0.411
AC:
6230
AN:
15166
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
1451
AN:
3460
East Asian (EAS)
AF:
0.331
AC:
1709
AN:
5156
South Asian (SAS)
AF:
0.374
AC:
1790
AN:
4792
European-Finnish (FIN)
AF:
0.541
AC:
5598
AN:
10348
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.435
AC:
29529
AN:
67868
Other (OTH)
AF:
0.416
AC:
866
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1842
3684
5526
7368
9210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.427
Hom.:
6734
Bravo
AF:
0.420

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19581274, 11810296)

not specified Benign:1
Feb 22, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
12
DANN
Benign
0.87
PhyloP100
0.024
Mutation Taster
=46/54
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10451941; hg19: chr3-193355102; COSMIC: COSV62479516; COSMIC: COSV62479516; API